Tight perioperative glycemic control using an artificial endocrine pancreas

Surgery Today

Volumn 40, Issue 1, 2010, Pages 1-7

  Hanazaki, Kazuhiro ^a   Maeda, Hiromichi ^a   Okabayashi, Takehiro ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

Artificial pancreas; Glycemic control; Intensive insulin therapy; STG 22

Indexed keywords

ADULT; ARTIFICIAL PANCREAS; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE INSULIN THERAPY; PERIOPERATIVE PERIOD; POSTOPERATIVE INFECTION; REVIEW;

ANIMALS; BLOOD GLUCOSE; CRITICAL ILLNESS; DIABETES COMPLICATIONS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFECTION CONTROL; INSULIN; ISLETS OF LANGERHANS; PANCREAS, ARTIFICIAL; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; TIME FACTORS;

EID: 76849108109     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-009-4061-2     Document Type: Review

References (43)

1. G. Van den Berghe P. Wouters F. Weekers C. Verwaest F. Bruyninckx M. Schetz, et al. 2001 Intensive insulin therapy in critically ill patients N Engl J Med 345 1359 1367 10.1056/NEJMoa011300 11794168 (Pubitemid 34940724)
2. G. Van den Berghe A. Wilmer G. Hermans W. Meersseman P.J. Wouters I. Milants, et al. 2006 Intensive insulin therapy in the medical ICU N Engl J Med 354 449 461 10.1056/NEJMoa052521 16452557 (Pubitemid 43200296)
3. J.S. Krinsley 2004 Effects of an intensive glucose management protocol on the mortality of critically ill adult patients Mayo Clin Proc 79 992 1000 10.4065/79.8.992 15301325
4. D. Klein T. Schubert R.E. Horch K.W. Jauch M.G. Jeschke 2004 Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma Ann Surg 240 340 349 10.1097/01.sla.0000133353. 57674.cd 15273560 (Pubitemid 38963027)
5. J. McMullin J. Brozek R. Jaeschke C. Hamielec V. Dhingra G. Rocker, et al. 2004 Glycemic control in the ICU: a multicenter survey Intensive Care Med 30 798 803 10.1007/s00134-004-2242-4 15052384 (Pubitemid 38639469)
6. S. Kanji J. Buffie B. Hutton P.S. Bunting A. Singh K. McDonald, et al. 2005 Reliability of point-of-care testing for glucose measurement in critically ill adults Crit Care Med 33 2778 2785 10.1097/01.CCM.0000189939.10881.60 16352960 (Pubitemid 41816412)
7. M.J. Schultz P. Spronk H. Moeniralam 2006 Tight glycemic control: a survey of intensive care practice in the Netherlands Intensive Care Med 32 618 619 10.1007/s00134-006-0099-4 16501942
8. T.M. Vriesendorp J.H. DeVries S. van Santen H.S. Moeniralam E. de Jonge Y.B. Roos, et al. 2006 Evaluation of short-term consequences of hypoglycemia in an intensive care unit Crit Care Med 34 2714 2718 10.1097/01.CCM.0000241155. 36689.91 1:CAS:528:DC%2BD28XhtV2rsrbP 16943734 (Pubitemid 44610935)
9. J.S. Krinsley R.L. Jones 2006 Cost analysis of intensive glycemic control in critically ill adult patients Chest 129 644 650 10.1378/chest.129.3.644 16537863
10. I. Mitchell S. Finfer R. Bellomo T. Higlett Anzics Clinical Trials Group Glucose Management Investigators 2006 Management of blood glucose in the critically ill in Australia and New Zealand: a practice survey and inception cohort study Intensive Care Med 32 867 874 10.1007/s00134-006-0135-4 16622639 (Pubitemid 43781368)
11. G. Van den Berghe K. Schoonheydt P. Becx F. Bruyninckx P.J. Wouters 2005 Insulin therapy protects the central and peripheral nervous system of intensive care patients Neurology 64 1348 1353 15851721
12. G. Van den Berghe P.J. Wouters K. Kesteloot D.E. Hilleman 2006 Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients Crit Care Med 34 612 616 16521256
13. M. Ramos Z. Khaipey S. Lipsitz J. Steinberg M.T. Panizales M. Zinner, et al. 2008 Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery Ann Surg 248 585 591 18936571
14. S. Ambiru A. Kato F. Kimura H. Shimizu H. Yoshidome M. Otsuka, et al. 2008 Poor postoperative blood glucose control increases surgical site infections after surgery for hepato-biliary-pancreatic cancer: a prospective study in a high-volume institute in Japan J Hosp Infect 68 230 233 1:STN:280: DC%2BD1c7otlelsQ%3D%3D 18294725
15. G. Van den Berghe 2008 Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/l and 6.1 mmol/l Diabetologia 51 911 915 10.1007/s00125-007-0878-7 18040662 (Pubitemid 351624498)
16. R. Fietsam Jr J. Bassett J.L. Glover 1991 Complications of coronary artery surgery in diabetic patients Ann Surg 57 551 557
17. P.A. O'Neill I. Davies K.J. Fullerton D. Bennett 1991 Stress hormone and blood glucose response following acute stroke in the elderly Stroke 22 842 847 1853403
18. J.F. Scott G.M. Robinson J.M. French J.E. O'Connell K.G. Alberti C.S. Gray 1999 Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the glucose insulin in stroke trial (GIST) Stroke 30 793 799 1:CAS:528:DyaK1MXisVOls7c%3D 10187881
19. L.M. McManus R.C. Bllodworth T.J. Prihoda J.L. Blodgett R.N. Pinckard 2001 Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia J Leukoc Biol 70 395 404 1:CAS:528: DC%2BD3MXmvVyhtrw%3D 11527989
20. G. Van den Berghe P.J. Wouters R. Bouillon F. Weekers C. Verwaest M. Schetz, et al. 2003 Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control Crit Care Med 31 359 366 10.1097/01.CCM.0000045568.12881.10 12576937 (Pubitemid 36232926)
21. R.P. Dellinger M. Levy J. Cartlet J. Bion M.M. Parker R. Jaeschke, et al. 2008 Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock Intensive Care Med 34 17 60 10.1007/s00134-007- 0934-2 18058085
22. F.M. Runkhorst C. Engel F. Bloos A. Meier-Hellmann M. Ragaller N. Weiler, et al. 2008 German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis N Engl J Med 358 125 139 10.1056/NEJMoa070716
23. National Institutes of Health. Glucontrol study. Comparing the effects of two glucose control regimens by insulin in intensive care unit patients. ClinicalTrials.gov identifier: NCT 00107601.
24. NICE-SUGAR Study Investigators S. Finfer D.R. Chittock S.Y. Su D. Blair D. Foster V. Dhingra, et al. 2009 Intensive versus conventional glucose control in critically ill patients N Engl J Med 360 1283 1297 10.1056/NEJMoa0810625 19318384
25. R.S. Wiener D.C. Wiener R.J. Larson 2008 Benefits and risks of tight glucose control in critically ill adults JAMA 300 933 944 10.1001/jama.300.8.933 1:CAS:528:DC%2BD1cXhtVGrt7nO 18728267
26. F. Billota A. Spinelli F. Giovannini A. Doronzio R. Edlfini G. Rosa 2007 The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial J Neurosurg Anesthesiol 19 156 160 10.1097/ANA. 0b013e3180338e69 (Pubitemid 47012351)
27. A. Aljada H. Ghanim P. Mohanty N. Kapur P. Dandona 2002 Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations J Clin Endocrinol Metab 87 1419 1422 10.1210/jc.87.3.1419 1:CAS:528:DC%2BD38XitlWnt7g%3D 11889219 (Pubitemid 36121118)
28. P. Dandona A. Aljada P. Mohanty H. Ghanim W. Hamouda E. Assian, et al. 2001 Insulin inhibits intranuclear nuclear factor κB and stimulates iκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 86 3257 3265 10.1210/jc.86.7.3257 1:CAS:528:DC%2BD3MXlt1GjtLk%3D 11443198 (Pubitemid 32674120)
29. A. Aljada H. Ghanim P. Mohanty T. Syed A. Bandyopadhyay P. Dandona 2004 Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations Am J Clin Nutr 80 51 57 1:CAS:528: DC%2BD2cXltlKltro%3D 15213027
30. H. Iwasaka 2008 Anti-inflammatory effects of insulin (abstract in English) ICU & CCU 32 821 831
31. K. Hanazaki Y. Nosé F.C. Brunicardi 2001 Artificial endocrine pancreas: a review J Am Coll Surg 193 310 322 10.1016/S1072-7515(01)01014-6 1:STN:280:DC%2BD3MvpvFylsg%3D%3D 11548802 (Pubitemid 32834768)
32. K. Yamashita T. Okabayashi T. Yokoyama T. Yatabe H. Maeda M. Manabe, et al. 2008 The accuracy of a continuous blood glucose monitor during surgery Anesth Analg 106 1 160 163 10.1213/01.ane.0000296461.26492.3c 18165572
33. K. Yamashita T. Okabayashi T. Yokoyama T. Yatabe H. Maeda M. Manabe, et al. 2009 Accuracy and reliability of continuous blood glucose monitoring in post-surgical patients Acta Anaesthesiol Scand 53 1 66 71 10.1111/j.1399-6576. 2008.01799.x 1:STN:280:DC%2BD1M%2Fls1yjtA%3D%3D 19032568
34. T. Okabayashi K. Hanazaki I. Nishimori T. Sugimoto H. Maeda T. Yatabe, et al. 2008 Continuous post-operative blood monitoring and control using a closed-loop system in patients undergoing hepatic resection Dig Dis Sci 53 1405 1410 10.1007/s10620-007-0010-3 1:CAS:528:DC%2BD1cXksFahurc%3D 17934862
35. T. Kono K. Hanazaki K. Yazawa S. Ashizawa W.E. Fisher X.P. Wang, et al. 2005 Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs Artif Organs 29 83 87 10.1111/j.1525-1594.2004.29008.x 15644089 (Pubitemid 41602009)
36. K.J. Zerr A.P. Furnary G.L. Grunkemeier S. Bookin V. Kanhere A. Starr 1997 Glucose control lowers the risk of wound infection in diabetes after open heart operations Ann Thorac Surg 63 356 361 10.1016/S0003-4975(96)01044-2 1:STN:280:DyaK2s7osFKiuw%3D%3D 9033300 (Pubitemid 27084552)
37. A.P. Furnary K.J. Zerr G.L. Grunkemeier A. Starr 1999 Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures Ann Throc Surg 67 352 362 10.1016/S0003-4975(99)00014-4 1:STN:280:DyaK1M3htFGisg%3D%3D (Pubitemid 29176984)
38. T. Okabayashi I. Nishimori K. Yamashita T. Sugimoto H. Maeda T. Yatabe, et al. 2009 Continuous postoperative blood glucose monitoring and control by an artificial pancreas in patients undergoing pancreatic resection: a prospective randomized clinical trial Arch Surg 144 933 937 10.1001/archsurg.2009.176 19841361
39. T. Okabayashi I. Nishimori H. Maeda K. Yamashita T. Yatabe K. Hanazaki 2009 Effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial Diabetes Care 32 1425 1427 10.2337/dc08-2107 1:CAS:528:DC%2BD1MXhtV2gsL7F 19435954
40. R.J. Rafoth 2002 Standardizing sliding scale insulin orders Am J Med Qual 17 175 178 10.1177/106286060201700503 12412944
41. K. Hanazaki T. Okabayashi H. Maeda 2009 Tight glycemic control using an artificial pancreas to control perioperative hyperglycemia decreases surgical site infection in pancreatectomized or hepatectomozied patients Ann Surg 250 351 352 10.1097/SLA.0b013e3181b1e994
42. K. Hanazaki T. Okabayashi H. Maeda H. Kitagawa T. Sugimoto T. Yatabe, et al. 2008 Perioperative blood glucose control using artificial endocrine pancreas (abstract in English) ICU & CCU 32 805 813
43. K. Hanazaki T. Okabayashi H. Maeda T. Yatabe K. Yamashita I. Nishimori, et al. 2008 Perioperative blood glucose control using artificial endocrine pancreas-Importance of perioperative strict glycemic control (in Japanese) Tan & Sui 29 861 866